What is Hodgkin lymphoma? Is it good to cure?

2021-11-11 10:33:39

[]

Previous: Starting from a case, we will talk about the optimization of second-line treatment of classical Hodgkin lymphoma

Next: The first general under Lin Biao was killed in a cold gun, and Chairman Mao presided over the memorial service and praised his merits

Read on

Association between treatment regimen intensity and prognosis in elderly hodgkin lymphoma patients
Hodgkin 's
10-27
2021 CSCO 丨SCO 丨 Professor Li Zhiming: Treatment progress of Hodgkin lymphoma
professor Li Zhi Hodgkin 's
10-27
Professor Song Yuqin | A curable lymphoma - classical Hodgkin lymphoma: What are the precautions for patients with classic Hodgkin lymphoma during chemotherapy?
professor Hodgkin 's
10-27
About Hodgkin's disease
Hodgkin 's
10-27
2021 CSCO | Professor Cao Junning: Treatment progress of Hodgkin lymphoma
professor Hodgkin 's
10-27
New possibilities for treatment for patients with Hodgkin lymphoma
China Biopharmaceutical announced on August 5 that the innovative drug of tumor immunology, Pisaprizumab Injection (trade name: Annicol ®) has officially been approved by the State Drug Administration and can be used to...
Hodgkin 's
10-27
What the hell is "non-Hodgkin lymphoma"? It was it, the bad guy who took BearTon away
Hodgkin 's
10-27
Clinical features and treatment status of primary Wechsler ring non-Hodgkin lymphoma
Hodgkin 's
10-27
Nobel laureate and "female magician" Dorothy Hodgkin, has an indissoluble relationship with China
Hodgkin 's
10-31
For the first time, the clinical trial of The new drug of Deqi Pharmaceutical was approved in the United States for solid tumors and non-Hodgkin lymphoma
Beijing News (reporter Liu Xu) On November 1, Deqi Pharmaceutical issued an announcement announcing that the US Food and Drug Administration has approved the company's ATG-101 new drug clinical trial (IND...
Hodgkin 's
11-01
Deqi Pharmaceuticals was approved by the US FDA for a new drug research application for ATG-101 (PD-L1/4-1BB dual antibody) for the treatment of solid tumors and non-Hodgkin lymphoma Phase I trials
Hodgkin 's
11-01
Summary of recent research advances in classical Hodgkin lymphoma (medium)
Hodgkin 's
11-11
Celestial Creatures (IMAB. US) announced that it will publish data from clinical trials of zolizumab in combination with rituximab for the treatment of non-Hodgkin lymphoma
Zhitong Finance APP learned that Tianjing Bio (IMAB. US) recently announced that the 63rd Annual Meeting of the American Society of Hematology will be held from December 11 to 14, 2021...
Hodgkin 's
11-11
What is Hodgkin mixed lymphoma? What treatment options are available?
Hodgkin 's
11-11
Starting from a case, we will talk about the optimization of second-line treatment of classical Hodgkin lymphoma
Hodgkin 's
11-11